Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory

New services to enable U.S. biopharmaceutical companies to accelerate development of biosimilar[more]

Date 10.11.2016     Category Corporate, Sartorius Stedim Biotech

Nine-month Figures for 2016: Sartorius Continues to Grow by Strong Double Digits

Dynamic growth for the Bioprocess Solutions Division; positive development of the Lab Products & Services Division | Earnings increased by around one-fourth | Guidance for the full year of 2016...[more]

Date 24.10.2016     Category Corporate, Sartorius

Nine-month Figures for 2016: Sartorius Stedim Biotech continues on the growth track

€ in millions unless otherwise specified9 months 20169 months 2015Growth in %Growth in %const. fx Sales revenue785.1660.918.820.4EMEA1342.7299.514.416.2Americas1290.2242.419.721.0Asia |...[more]

Date 24.10.2016     Category Corporate, Sartorius Stedim Biotech

CFO Jörg Pfirrmann has decided to leave Sartorius by mid-2017

Göttingen, October 11, 2016 - Jörg Pfirrmann, member of the Executive Board of Sartorius AG, has informed the Supervisory Board to be not available for an extension of his contract, which would be up...[more]

Date 11.10.2016     Category Corporate, Sartorius

Sartorius Stedim Biotech launches two Single-use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane

Assemblies save up to 60 percent on processing time and offer a safe approach to ultrafiltration of biologics and vaccines[more]

Date 30.09.2016     Category Products, Sartorius Stedim Biotech